Intra-bronchial device that provides a medicant intra-bronchially to the patient

• US 20030154988A1
• Filed: 06/21/2002
• Published: 08/21/2003
• Est. Priority Date: 02/21/2002
• Status: Abandoned Application

• Current Assignee: Gyrus ACMI, Inc. (Olympus Corporation)
• Original Assignee: Spiration, Inc. (Olympus Corporation)
• Inventors: DeVore, Lauri J., Gonzalez, Hugo X., Shea, Richard O., Springmeyer, Steven Chase, Wang, John H.
• Application Number:
  US10/178,073
• Publication Number:
  US 20030154988A1
• Time in Patent Office: Days
• US Class Current: 128/207.15
• CPC Class Codes: A61B 17/12022 Occluding by internal devices, e.g. balloons or releasable wires plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20
• CPC Class Codes: A61B 17/12036 partial occlusion
• CPC Class Codes: A61B 17/1204 temporary occlusion
• CPC Class Codes: A61B 17/12104 in an air passage
• CPC Class Codes: A61B 17/12159 Solid plugs; being solid before insertion
• CPC Class Codes: A61B 17/12172 having a pre-set deployed three-dimensional shape methods of manufacturing A61B2017/00526
• CPC Class Codes: A61B 2017/1205 Introduction devices
• CPC Class Codes: A61B 2017/22051 with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation A61B2017/22048, A61B2017/3486 take precedence
• CPC Class Codes: A61B 2017/22067 Blocking; Occlusion A61B2017/22054 takes precedence
• CPC Class Codes: A61B 2017/242 for bronchial passages
• CPC Class Codes: A61B 2217/005 with suction drainage system
• CPC Class Codes: A61F 2002/043 Bronchi
• CPC Class Codes: A61M 1/78 Means for preventing overflow or contamination of the pumping systems combined with drainage containers A61M1/60
• CPC Class Codes: A61M 2025/0076 Unidirectional valves
• CPC Class Codes: A61M 2210/1035 Bronchi
• CPC Class Codes: A61M 25/04 in the body, e.g. expansible A61M25/10, A61M16/0488 take precedence
• CPC Class Codes: A61M 31/00 Devices for introducing or retaining media, e.g. remedies, in cavities of the body A61M25/00 takes precedence ; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008
• CPC Class Codes: A61N 2005/1021 Radioactive fluid
• CPC Class Codes: A61N 5/1027 Interstitial radiation therapy

Abstract

An intra-bronchial device provides a medicant intra-bronchially. The medicant may be used for controlling biological interaction of an intra-bronchial obstruction device with the patient, to treat a disease or condition of the lungs such as pneumonia or lung cancer, or to treat a systemic disease or condition. The medicant is provided by associating a medicant with the intra-bronchial device, either before, at the time of placement, or after placement. The medicant may overlie at least a portion of the intra-bronchial device, be absorbed into at least a portion of the intra-bronchial device, or be carried in a chamber. The intra-bronchial device may further include an absorptive member, and the medicant is absorbed by the absorptive member.

Claims

1. An intra-bronchial device adapted to be placed in an air passageway of a patient to collapse a lung portion communicating with the air passageway, the device comprising:

an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion; and

a medicant carried by the obstructing member that controls biological interaction of the device with the patient.

2. The device of claim 1, wherein the medicant overlies at least a portion of the obstructing member.

3. The device of claim 1, wherein the medicant is imbedded in at least a portion of the obstructing member.

4. The device of claim 1, wherein the medicant is absorbed in at least a portion of the obstructing member.

5. The device of claim 1, wherein the obstructing member further includes an absorptive member and the medicant is absorbed by the absorptive member.

6. The device of claim 1, wherein the medicant is selected from a group consisting of tissue growth inhibitors, tissue growth enhancers, anti-microbial agents such as antibiotic agents or antibacterial agents, anti-inflammatory agents, and biological reaction inhibitors.

7. The device of claim 1, wherein the medicant is arranged to control biological interaction over a period of time.

8. The device of claim 1, wherein the medicant is co-mixed with at least a portion of the obstructing member.

9. An intra-bronchial device adapted to be placed in an air passageway of a patient to collapse a lung portion communicating with the air passageway, the device comprising:

an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion;

a medicant that controls biological interaction of the device with the patient; and

a cavity in the obstructing member carrying the medicant.

10. The device of claim 9, wherein the medicant is selected from a group consisting of tissue growth inhibitors, tissue growth enhancers, anti-microbial agents such as antibiotic agents or antibacterial agents, anti-inflammatory agents, and biological reaction inhibitors.

11. The device of claim 9, wherein the medicant is arranged to control biological interaction over a period of time.

12. The device of claim 9, wherein the cavity further includes an absorptive member and the medicant is absorbed by the absorptive member.

13. The device of claim 9, wherein the cavity includes a cover having an orifice.

14. An intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion communicating with the air passageway, the device comprising:

an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion;

a medicant that controls biological interaction of the device with the patient; and

a support structure that is associated with the obstructing member and that carries the medicant.

15. The device of claim 14, wherein the medicant overlies at least a portion of the intra-bronchial device.

16. The device of claim 14, wherein the medicant is imbedded in at least a portion of the intra-bronchial device.

17. The device of claim 14, wherein the medicant is absorbed in at least a portion of the intra-bronchial device.

18. The device of claim 14, wherein the medicant is selected from a group consisting of tissue growth inhibitors, tissue growth enhancers, anti-microbial agents such as antibiotic agents or antibacterial agents, anti-inflammatory agents, and biological reaction inhibitors.

19. The device of claim 14, wherein the medicant is arranged to control biological interaction over a period of time.

20. A method of reducing the size of a lung of a patient using an intra-bronchial device while controlling biological interaction of the device with the patient, the method including the steps of:

providing an intra-bronchial device that precludes air from being inhaled through an air passageway into a lung portion to be reduced in size when inserted into the air passageway communicating with the portion of the lung;

associating a medicant that controls the biological interaction with the intra-bronchial device; and

inserting the intra-bronchial device in the air passageway.

21. The method of claim 20, wherein the step of associating the medicant with the intra-bronchial device is performed before the step of implanting the device.

22. The method of claim 20, wherein the step of associating the medicant with the intra-bronchial device includes overlying at least a portion of the intra-bronchial device with the medicant.

23. The method of claim 20, wherein the step of associating the medicant with the intra-bronchial device includes impregnating at least a portion of the intra-bronchial device with the medicant.

24. The method of claim 20, wherein the intra-bronchial device includes an absorptive member, and wherein the step of associating the medicant with the intra-bronchial device includes absorption of the medicant by the absorptive member.

25. The method of claim 20, wherein the medicant is selected from a group consisting of tissue growth inhibitors, tissue growth enhancers, anti-microbial agents such as antibiotic agents or antibacterial agents, anti-inflammatory agents, and biological reaction inhibitors.

26. The method of claim 20, wherein the medicant is arranged to control biological interaction over a period of time.

27. The method of claim 20, including the further steps of providing a cavity in the intra-bronchial device for receiving the medicant, and associating the medicant with the cavity.

28. The method of claim 27, wherein the step of associating the medicant with the intra-bronchial device is performed before the step of implanting the device.

29. The method of claim 27, wherein the cavity includes an absorptive member, and wherein the step of associating medicant with the intra-bronchial device includes absorption of the medicant by the absorptive member.

30. The method of claim 20, wherein the medicant is selected from a group consisting of tissue growth inhibitors, tissue growth enhancers, anti-microbial agents such as antibiotic agents or antibacterial agents, anti-inflammatory agents, and biological reaction inhibitors.

31. The method of claim 20, wherein the medicant is arranged to control biological action over a period of time.

32. An intra-bronchial device to provide a medicant intra-bronchially to a patient, the device comprising:

an intra-bronchial member adapted to be placed in an air passageway; and

a medicant carried on the intra-bronchial member.

33. The intra-bronchial device of claim 32, further including a cavity in the intra-bronchial member, and the medicant is carried in the cavity.

34. The intra-bronchial device of claim 32, wherein the medicant is arranged for delivery to a lung portion communicating with the air passageway.

35. The intra-bronchial device of claim 32, wherein the medicant is selected from a group consisting of antibacterial agents, antiviral agents, anthelmintic agents, anti-inflammatory agents, antitumor agents, radioprotective agents, antioxidant agents, adrenergic agents, hormonal agents, and radioactive branchytherapy material.

61. The intra-bronchial device of claim 32, wherein the intra-bronchial member is arranged to preclude air movement in at least one direction.

62. The intra-bronchial device of claim 32, wherein the medicant overlies at least a portion of the intra-bronchial member.

63. The intra-bronchial device of claim 32, wherein the medicant is imbedded in at least a portion of the intra-bronchial member.

64. The intra-bronchial device of claim 32, wherein the medicant is absorbed in at least a portion of the intra-bronchial member.

65. The intra-bronchial device of claim 32, wherein the intra-bronchial member further includes an absorptive member and the medicant is absorbed by the absorptive member.

66. The intra-bronchial device of claim 32, the medicant is co-mixed with at least a portion of the intra-bronchial member.

67. The intra-bronchial device of claim 32, wherein the medicant is arranged to be released over a period of time.

36. An intra-bronchial device adapted to be placed in an air passageway and provide a medicant to a patient, the device comprising:

an obstructing member that prevents air from being exhaled from the lung portion communicating with the air passageway; and

a medicant carried on the obstructing member.

37. The device of claim 36, wherein the medicant is arranged for delivery to the lung portion.

38. The device of claim 36, wherein the medicant is carried on a portion of the obstructing member exposed to the lung portion.

39. The device of claim 36, wherein the obstructing member when deployed in the air passageway substantially precludes released medicant from moving proximal to the obstructing member.

40. The device of claim 36, wherein the medicant overlies at least a portion of the obstructing member.

41. The device of claim 36, wherein the medicant is imbedded in at least a portion of the obstructing member.

42. The device of claim 36, wherein the medicant is absorbed in at least a portion of the obstructing member.

43. The device of claim 36, wherein the obstructing member further includes an absorptive member and the medicant is absorbed by the absorptive member.

44. The device of claim 36, wherein the medicant is selected from a group consisting of antibacterial agents, antiviral agents, anthelmintic agents, anti-inflammatory agents, antitumor agents, radioprotective agents, antioxidant agents, adrenergic agents, hormonal agents, and radioactive branchytherapy material.

45. The device of claim 36, wherein the medicant is arranged to control biological action over a period of time.

46. The device of claim 36, wherein the medicant is co-mixed with at least a portion of the obstructing member.

47. An intra-bronchial device adapted to be placed in an air passageway and provide a medicant to a patient, the device comprising:

an obstructing member that prevents air from being exhaled from the lung portion communicating with the air passageway;

a medicant; and

a cavity in the obstructing member carrying the medicant.

48. The intra-bronchial device of claim 47, wherein the cavity further includes an absorptive member and the medicant is absorbed by the absorptive member.

49. The intra-bronchial device of claim 47, wherein the cavity includes a cover having an orifice affecting release of the medicant.

50. The device of claim 47, wherein the medicant is exposed to the lung portion.

51. The device of claim 47, wherein the obstructing member when deployed in the air passageway substantially precludes released medicant from moving proximal to the obstructing member.

52. An intra-bronchial device adapted to be placed in an air passageway and provide a medicant to a patient, the device comprising:

an obstructing member that prevents air from being exhaled from the lung portion communicating with the air passageway;

a medicant; and

a support structure that is associated with the obstructing member and that carries the medicant.

53. A method of providing a medicant to a patient using an intra-bronchial device, the method including the steps of:

providing an intra-bronchial device for insertion into an air passageway in communication with a lung portion;

associating a medicant with the intra-bronchial device; and

inserting the intra-bronchial device in the air passageway.

54. The method of claim 53, wherein the intra-bronchial device precludes air from being exhaled through the air passageway when inserted into the air passageway.

55. The method of claim 53, wherein the medicant is an agent for treating a disease of the lungs, and the medicant is provided to treat a disease in the lung portion.

56. The method of claim 53, wherein the medicant is an agent for treating pneumonia, and the medicant is provided to treat pneumonia in the lung portion.

57. The method of claim 53, wherein the medicant is a radioactive material for treating cancer, and the medicant is provided to treat a cancer.

58. The method of claim 53, wherein the medicant is a radioactive material for treating cancer, and the medicant is provided to treat a cancer in the lung portion.

59. A device for reducing the size of a lung of a patient, the device comprising:

obstructing means for obstructing an air passageway communicating with a portion of the lung to be reduced in size, the obstructing means being dimensioned for insertion into the air passageway and for precluding air from being inhaled through the air passageway into the lung portion; and

means for controlling biological action of the obstructing means with the patient.

60. An intra-bronchial device adapted to be placed in an air passageway and provide a medicant to a patient, the device comprising:

obstructing means for obstructing an air passageway that prevents air from being exhaled from the lung portion communicating with the air passageway, the obstructing means being dimensioned for insertion into the air passageway and for precluding air from being exhaled through the air passageway into the lung portion; and

means for providing a biological action in the patient carried by the obstructing means.